Insulin binding to myotonic dystrophy fibroblasts.

Area of Science:

• Endocrinology
• Cell Biology
• Genetics

Background:

• Myotonic dystrophy (MyD) is a multisystemic disorder.
• Previous studies indicated altered insulin receptor binding in monocytes of MyD patients.
• Skin fibroblasts offer an alternative model for studying cellular defects in MyD.

Purpose of the Study:

• To investigate insulin receptor binding in cultured skin fibroblasts from myotonic dystrophy patients.
• To compare binding capacity and affinity with age- and sex-matched control subjects.
• To determine if fibroblast insulin binding abnormalities mirror those found in monocytes.

Main Methods:

• Cultured skin fibroblasts were obtained from 10 myotonic dystrophy patients and 10 controls.
• Insulin binding assays were performed under optimized conditions (HEPES buffer, pH 8.0, 15°C, 5h).
• Insulin binding capacity and affinity were quantified using labeled and unlabeled insulin.

Main Results:

• A significant 62% reduction in normalized initial insulin binding capacity was observed in myotonic dystrophy fibroblasts (1.93% ± 0.13%) compared to controls (5.04% ± 0.28%).
• This decrease was primarily attributed to a reduction in high-affinity receptors or receptor affinity.
• Competition studies with unlabeled insulin confirmed significantly lower binding in the MyD group.

Conclusions:

• Cultured skin fibroblasts from myotonic dystrophy patients exhibit markedly reduced insulin receptor binding.
• These findings support the hypothesis of a surface membrane defect in myotonic dystrophy.
• The observed defect in fibroblasts is consistent with previous findings in monocytes, suggesting a systemic membrane abnormality.